SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001415889-14-003942
Filing Date
2014-12-19
Accepted
2014-12-19 12:03:16
Documents
4
Period of Report
2014-12-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ecte8kdec182014.htm 8-K 35386
2 LETTER FROM NASDAQ TO THE COMPANY DATED DECEMBER 18, 2014 ex99-1.htm EX-99.1 2359
3 nasd.jpg GRAPHIC 16560
4 sig.jpg GRAPHIC 3494
  Complete submission text file 0001415889-14-003942.txt   67159
Mailing Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103
Business Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 215-717-4100
Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35218 | Film No.: 141298137
SIC: 3845 Electromedical & Electrotherapeutic Apparatus